SCHEMBL2297863

SCHEMBL2297863

CCN(C(=O)c1ccccc1OC)c1nnc(-c2ccc(C=O)cc2)s1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 6/20 0.63
NPC1 O15118 5/20 0.63
L3MBTL1 Q9Y468 1/20 0.63
KDM4E B2RXH2 6/20 0.58
MEN1 O00255 2/20 0.58
KMT2A Q03164 2/20 0.58
CYP1A2 P05177 1/20 0.58
GAA P10253 1/20 0.58
CYP2D6 P10635 1/20 0.58
CYP2C9 P11712 1/20 0.58
CYP2C19 P33261 1/20 0.58
S1PR1 P21453 5/20 0.58
USP2 O75604 1/20 0.55
ALDH1A1 P00352 4/20 0.54
TP53 P04637 3/20 0.54
HPGD P15428 2/20 0.54
SMN1; SMN2 Q16637 2/20 0.54
NPSR1 Q6W5P4 1/20 0.54
RXFP1 Q9HBX9 1/20 0.54
CPB1 P15086 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2299749 0.91 S1PR1 (0.71) RAB9ANPC1L3MBTL1KDM4EMEN1
SCHEMBL2299676 0.85 S1PR1 (0.58) RAB9ANPC1L3MBTL1KDM4EMEN1
SCHEMBL2300532 0.85 S1PR1 (0.65) RAB9ANPC1KDM4EMEN1KMT2A
SCHEMBL2298027 0.82 S1PR1 (0.70) RAB9ANPC1L3MBTL1KDM4EMEN1
SCHEMBL2300347 0.82 S1PR1 (0.53) RAB9ANPC1L3MBTL1KDM4EMEN1
SCHEMBL1647950 0.80 CPB1 (0.72) RAB9ANPC1L3MBTL1KDM4EMEN1
SCHEMBL2298394 0.80 S1PR1 (0.54) RAB9ANPC1KDM4ES1PR1ALDH1A1
SCHEMBL1966144 0.80 S1PR1 (0.85) RAB9ANPC1L3MBTL1KDM4EMEN1
SCHEMBL2297953 0.79 KDM4E (0.55) RAB9ANPC1L3MBTL1KDM4EMEN1
SCHEMBL2296865 0.78 S1PR1 (0.65) S1PR1ALDH1A1SMN1; SMN2CPB1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110200557-A1 NEW 2-AMIDOTHIADIAZOLE DERIVATIVES ALMIRALL, S.A. (ES) 2011-08-18 US disclosed
US-20110200557-A1 NEW 2-AMIDOTHIADIAZOLE DERIVATIVES ALMIRALL, S.A. (ES) 2011-08-18 US disclosed
US-20110200557-A1 NEW 2-AMIDOTHIADIAZOLE DERIVATIVES ALMIRALL, S.A. (ES) 2011-08-18 US disclosed
WO-2010043377-A1 NEW 2-AMIDOTHIADIAZOLE DERIVATIVES ALMIRALL, S.A. (ES) 2010-04-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110200557-A1 NEW 2-AMIDOTHIADIAZOLE DERIVATIVES S1PR2, S1PR3, S1PR1 RAB9A 3103/4885NPC1 378/4885L3MBTL1 4148/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.